Over the last 7 days, the Life Sciences industry has remained flat. As for the the longer term, the industry is up 5.5% over the past 12 months. As for the next few years, earnings are expected to grow by 119% per annum.
Has the Taiwanese Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 01 Feb 2023 | NT$49.8b | NT$2.7b | NT$85.3m | 19.3x | 583.6x | 18.6x |
Fri, 30 Dec 2022 | NT$50.0b | NT$2.7b | NT$85.3m | 18.8x | 586.4x | 18.7x |
Sun, 27 Nov 2022 | NT$51.3b | NT$2.7b | NT$139.5m | 18.5x | 367.9x | 19.2x |
Tue, 25 Oct 2022 | NT$43.7b | NT$3.0b | NT$482.8m | 23.1x | 90.5x | 14.6x |
Thu, 22 Sep 2022 | NT$45.6b | NT$3.0b | NT$482.8m | 25.6x | 94.4x | 15.2x |
Sat, 20 Aug 2022 | NT$41.7b | NT$3.0b | NT$498.3m | 25.2x | 83.6x | 13.7x |
Mon, 18 Jul 2022 | NT$38.5b | NT$3.1b | NT$325.1m | 37.3x | 118.3x | 12.5x |
Wed, 15 Jun 2022 | NT$40.7b | NT$3.1b | NT$325.1m | 36.6x | 125.2x | 13.3x |
Fri, 13 May 2022 | NT$28.8b | NT$2.9b | NT$80.8m | 27.4x | 356.8x | 9.8x |
Sun, 10 Apr 2022 | NT$34.8b | NT$3.2b | NT$164.4m | 27.6x | 211.4x | 10.9x |
Tue, 08 Mar 2022 | NT$34.2b | NT$3.0b | -NT$120,147,000.00 | 34.9x | -284.4x | 11.2x |
Thu, 03 Feb 2022 | NT$35.8b | NT$3.0b | -NT$120,147,000.00 | 34.3x | -298.1x | 11.8x |
Sat, 01 Jan 2022 | NT$39.0b | NT$3.0b | -NT$120,147,000.00 | 37.6x | -324.4x | 12.8x |
Mon, 29 Nov 2021 | NT$38.5b | NT$3.0b | -NT$120,147,000.00 | 37.9x | -320.4x | 12.6x |
Wed, 27 Oct 2021 | NT$29.4b | NT$2.8b | -NT$511,386,000.00 | 23.4x | -57.4x | 10.4x |
Fri, 24 Sep 2021 | NT$36.2b | NT$2.3b | -NT$631,150,000.00 | 31.8x | -57.3x | 15.6x |
Sun, 22 Aug 2021 | NT$36.7b | NT$2.3b | -NT$631,150,000.00 | 32x | -58.2x | 15.8x |
Fri, 09 Jul 2021 | NT$41.2b | NT$2.3b | -NT$631,150,000.00 | 33x | -65.3x | 17.7x |
Thu, 01 Apr 2021 | NT$27.9b | NT$2.2b | -NT$810,177,000.00 | 29x | -34.4x | 12.9x |
Sun, 03 Jan 2021 | NT$14.9b | NT$2.2b | -NT$912,568,000.00 | 25.2x | -16.3x | 6.7x |
Wed, 07 Oct 2020 | NT$19.2b | NT$2.1b | -NT$914,668,000.00 | 21.9x | -21x | 9x |
Tue, 30 Jun 2020 | NT$19.5b | NT$1.8b | -NT$1,161,248,000.00 | 20.7x | -16.8x | 10.7x |
Fri, 03 Apr 2020 | NT$8.0b | NT$1.8b | -NT$951,923,500.00 | 18.3x | -8.4x | 4.4x |
-9.5x
Which industries have driven the changes within the Taiwanese Healthcare industry?
TW Market | 2.33% | |
Healthcare | 3.71% | |
Life Sciences | 9.82% | |
Clinical Research and Equipment | 9.82% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6589 EirGenix | NT$117.00 | 7.3% +NT$2.4b | 16.4% | PS24x | |
6891 Locus Cell | NT$46.35 | 30.7% +NT$2.2b | n/a | PB4.8x | |
4133 Abnova (Taiwan) | NT$38.60 | 1.6% +NT$36.3m | -18.1% | PE37.9x | |
6661 Welgene BiotechLtd | NT$22.80 | 2.2% +NT$11.7m | 4.1% | PE20.7x |